Kelly Mac Donald Dynavax Technologies Corp (DVAX) insider trading activity

Kelly Mac Donald is SVP and CFO of DYNAVAX TECHNOLOGIES CORP. Currently has a direct ownership of 60,204 shares of DVAX, which is worth approximately $665,856. The most recent transaction as insider was on Dec 24, 2025, when has been sold 36,141 shares (Common Stock) at a price of $15.38 per share, resulting in proceeds of $555,848. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60.2K

105.99% 3M change

1179.03% 12M change

Total Value Held $665,856

Kelly MacDonald Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 24 2025	SELL Payment of exercise price or tax liability	$555,848 $15.38 p/Share	36,141 Reduced 37.51%	60,204 Common Stock
Dec 23 2025	BUY Exercise of conversion of derivative security	-	29,618 Added 23.51%	96,345 Common Stock
Dec 23 2025	BUY Grant, award, or other acquisition	-	37,500 Added 35.98%	66,727 Common Stock
Feb 18 2025	SELL Payment of exercise price or tax liability	$64,326 $12.93 p/Share	4,975 Reduced 14.55%	29,227 Common Stock
Feb 18 2025	BUY Exercise of conversion of derivative security	-	15,477 Added 31.15%	34,202 Common Stock
Feb 13 2025	SELL Payment of exercise price or tax liability	$67,485 $12.69 p/Share	5,318 Reduced 22.12%	18,725 Common Stock
Feb 13 2025	BUY Exercise of conversion of derivative security	-	16,000 Added 39.96%	24,043 Common Stock

Feb 10 2025	SELL Payment of exercise price or tax liability	$26,360 $13.2 p/Share	1,997 Reduced 19.89%	8,043 Common Stock
Feb 10 2025	BUY Exercise of conversion of derivative security	-	5,333 Added 34.69%	10,040 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$38,267 $12.82 p/Share	2,985 Reduced 38.81%	4,707 Common Stock
Feb 10 2024	BUY Exercise of conversion of derivative security	-	5,333 Added 40.94%	7,692 Common Stock
Feb 27 2023	SELL Payment of exercise price or tax liability	$30,821 $10.36 p/Share	2,975 Reduced 55.77%	2,359 Common Stock
Feb 27 2023	BUY Exercise of conversion of derivative security	-	5,334 Added 50.0%	5,334 Common Stock

Also insider at

IRWD

IRONWOOD PHARMACEUTICALS INC Healthcare

Chief Accounting Officer

Kelly Mac Donald

SVP and CFO

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DVAX shares.

Notify only if

Value

Insider Trading

Get notified when an Dynavax Technologies Corp insider buys or sells DVAX shares.

Notify only if

Operation

Value

Type

News

Receive news related to DYNAVAX TECHNOLOGIES CORP

Track Activities on DVAX

Account